Correlation Between BioNTech and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both BioNTech and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Takeda Pharmaceutical, you can compare the effects of market volatilities on BioNTech and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Takeda Pharmaceutical.

Diversification Opportunities for BioNTech and Takeda Pharmaceutical

0.22

Correlation Coefficient

BioNTech  Takeda Pharmaceutical

Modest diversification

The 3 months correlation between BioNTech and Takeda is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of BioNTech i.e., BioNTech and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between BioNTech and Takeda Pharmaceutical

Assuming the 90 days trading horizon BioNTech SE is expected to generate 2.8 times more return on investment than Takeda Pharmaceutical. However, BioNTech is 2.8 times more volatile than Takeda Pharmaceutical. It trades about -0.01 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about -0.09 per unit of risk. If you would invest  10,220  in BioNTech SE on April 24, 2025 and sell it today you would lose (530.00) from holding BioNTech SE or give up 5.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

BioNTech SE  vs.  Takeda Pharmaceutical

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BioNTech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Takeda Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with BioNTech and Takeda Pharmaceutical

The main advantage of trading using opposite BioNTech and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind BioNTech SE and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.